Literature DB >> 24093857

Atrial fibrillation in myocardial infarction patients: Impact on health care utilization.

Alanna M Chamberlain1, Suzette J Bielinski, Susan A Weston, Winslow Klaskala, Roger M Mills, Bernard J Gersh, Alvaro Alonso, Véronique L Roger.   

Abstract

BACKGROUND: Atrial fibrillation (AF) often complicates myocardial infarction (MI). While AF adversely impacts survival in MI patients, the impact of AF on health care utilization has not been studied.
METHODS: The risk of hospitalizations, emergency department (ED) visits, and outpatient visits associated with prior, new-onset (<30 days post-MI), and late-onset (≥30 days post-MI) AF was assessed among incident MI patients from the Olmsted County, Minnesota, community.
RESULTS: Of 1,502 MI patients, 237 had prior AF, 163 developed new-onset AF, 113 developed late-onset AF, and 989 had no AF. Over a mean follow-up of 3.9 years, 3,661 hospitalizations, 5,559 ED visits, and 80,240 outpatient visits occurred. After adjustment, compared with patients without AF, those with prior and new-onset AF exhibited a 1.6-fold and 1.3-fold increased risk of hospitalization, respectively. In contrast, late-onset AF carried a 2.2-fold increased risk of hospitalization. The hazard ratios were 1.4, 1.2, and 1.8 for ED visits and 1.4, 1.2, and 1.7 for outpatient visits for prior, new-onset, and late-onset AF. Additional adjustment for time-dependent recurrent MI and heart failure attenuated the results slightly for hospitalizations and ED visits; however, patients with late-onset AF still exhibited a >50% increased risk for both utilization measures.
CONCLUSIONS: In MI patients, the risk of hospitalizations, ED visits, and outpatient visits differed by the timing of AF onset, with the greatest risk conferred by late-onset AF. Atrial fibrillation imparts an adverse prognosis after MI, underscoring the importance of its management in MI patients.
© 2013.

Entities:  

Mesh:

Year:  2013        PMID: 24093857      PMCID: PMC3811034          DOI: 10.1016/j.ahj.2013.07.013

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  32 in total

1.  Comparison of computer-assigned Minnesota Codes with the visual standard method for new coronary heart disease events.

Authors:  J A Kors; R S Crow; P J Hannan; P M Rautaharju; A R Folsom
Journal:  Am J Epidemiol       Date:  2000-04-15       Impact factor: 4.897

2.  Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes.

Authors:  S S Rathore; A K Berger; K P Weinfurt; K A Schulman; W J Oetgen; B J Gersh; A J Solomon
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

3.  European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials.

Authors:  Fred S Apple; Alan H B Wu; Allan S Jaffe
Journal:  Am Heart J       Date:  2002-12       Impact factor: 4.749

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience.

Authors:  A D White; A R Folsom; L E Chambless; A R Sharret; K Yang; D Conwill; M Higgins; O D Williams; H A Tyroler
Journal:  J Clin Epidemiol       Date:  1996-02       Impact factor: 6.437

6.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

Authors:  T Killip; J T Kimball
Journal:  Am J Cardiol       Date:  1967-10       Impact factor: 2.778

7.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Authors:  J S Alpert; K Thygesen; E Antman; J P Bassand
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

Review 8.  Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.

Authors:  Cheuk-Kit Wong; Harvey D White; Robert G Wilcox; Douglas A Criger; Robert M Califf; Eric J Topol; E Magnus Ohman
Journal:  Card Electrophysiol Rev       Date:  2003-09

9.  Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

Authors:  H Tunstall-Pedoe; K Kuulasmaa; P Amouyel; D Arveiler; A M Rajakangas; A Pajak
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

Review 10.  Elevations in cardiac troponin measurements: false false-positives: the real truth.

Authors:  A S Jaffe
Journal:  Cardiovasc Toxicol       Date:  2001       Impact factor: 3.231

View more
  2 in total

Review 1.  Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation.

Authors:  Fahad Shaikh; Lachlan B Pasch; Phillip J Newton; Beata V Bajorek; Caleb Ferguson
Journal:  Curr Cardiol Rep       Date:  2018-03-24       Impact factor: 2.931

2.  Association Between Atrial Fibrillation and Costs After Myocardial Infarction: A Community Study.

Authors:  Bijan J Borah; Véronique L Roger; Roger M Mills; Susan A Weston; Stephanie S Anderson; Alanna M Chamberlain
Journal:  Clin Cardiol       Date:  2015-09-07       Impact factor: 2.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.